Table 8:

Results of the moderation analysis for specific and general anxiety scores and depression scores

ModeratorSMD (95% CI)zpQ1
Specific anxiety measure
 Session number−0.0414 (−0.1038 to 0.0209)−1.30190.191.6950
 Technique−0.2827 (−0.7443 to 0.1788)−1.20060.231.4415
 Target region−0.4963 (−1.2778 to 0.2852)−1.24470.211.5493
 Protocol type−0.4965 (−1.1366 to 0.1435)−1.52050.132.3118
General anxiety measure
 Session number−0.0723 (−0.1811 to 0.0364)−1.30390.191.7001
 Technique−0.1830 (−1.2449 to 0.8790)−0.33770.740.1140
 Target region−0.8212 (−2.2992 to 0.6568)−1.08900.281.1858
 Protocol type0.2243 (−1.2106 to 1.6592)0.30640.760.0939
Depression measure
 Session number−0.0777 (−0.1634 to 0.0080)−1.77600.076*3.1542
 Technique0.5794 (−0.7260 to 1.8847)0.86990.380.7567
 Target region−0.6709 (−2.9417 to 1.5998)−0.57910.560.3354
 Protocol type0.8540 (−0.5639 to 2.2718)1.18050.241.3935
 Comorbidity0.9563 (−0.3677 to 2.2803)1.41570.162.0042
  • CI = confidence interval; dlPFC = dorsolateral prefrontal cortex; iTBS = intermittent theta burst stimulation; rTMS = repetitive transcranial magnetic stimulation; SMD = standardized mean difference (effect size); tDCS = transcranial direct current stimulation. The applied technique (iTBS, rTMS, tDCS), target region (left vs. right dlPFC) and protocol type (excitatory v. inhibitory) moderators were categorical variables; session number was a numerical variable. For the depression outcome measure only, we computed whether the presence of comorbid depression influenced the outcome of the scores. z = z score associated with the SMD value; p = p value associated with the z score in the same row.

  • * p < 0.10.